Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J
Hepatology. 1984 Jan-Feb;4(1):53-8. doi: 10.1002/hep.1840040109.
The reticuloendothelial system phagocytic activity, estimated by the plasma elimination rate constant of 99mtechnetium-sulfur colloid, was studied in 41 decompensated cirrhotics and 10 normal subjects. The results were related to the incidence and type of bacterial infections occurring during hospitalization and follow-up, and to survival. The elimination rate constant of 99mtechnetium-sulfur colloid was lower in cirrhotic patients (0.168 +/- 0.007) (means +/- S.E.) than in normal subjects (0.220 +/- 0.005) (p less than 0.01). Cirrhotics were divided into two groups. Group I (16 patients) and Group II (25 patients) had normal or reduced elimination rate constant of 99mtechnetium-sulfur colloid, respectively. Both groups were similar in relation to clinical and biochemical data, hepatic blood flow, and wedged hepatic venous pressure. However, the liver scan and the elimination rate constant of indocyanine green were more altered in Group II. Patients in Group II developed acute bacterial infections more frequently than did patients in Group I. During hospitalization (24 +/- 2 days), bacteremia occurred in six patients in Group II and in none in Group I (p less than 0.05). During follow-up (28 +/- 3 months), 5 patients in Group II and none in Group I developed bacteremia (p less than 0.05). The cumulative survival rate of Group I patients was higher (p less than 0.05) than that of Group II patients at 3 months (100 vs. 80%), 6 months (94 vs. 68%), 24 months (74 vs. 42%), and 48 months (68 vs. 34%). We suggest that decompensated cirrhotics with depressed reticuloendothelial system phagocytic activity are at great risk to acquire bacteremia, and that reticuloendothelial system phagocytic activity has prognostic value in cirrhosis.
通过锝-99m硫胶体的血浆清除率常数来估算网状内皮系统的吞噬活性,对41例失代偿期肝硬化患者和10名正常受试者进行了研究。研究结果与住院期间及随访期间发生的细菌感染的发生率和类型以及生存率相关。肝硬化患者的锝-99m硫胶体清除率常数(0.168±0.007)(均值±标准误)低于正常受试者(0.220±0.005)(p<0.01)。肝硬化患者被分为两组。第一组(16例患者)和第二组(25例患者)的锝-99m硫胶体清除率常数分别正常或降低。两组在临床和生化数据、肝血流量以及肝静脉楔压方面相似。然而,第二组的肝脏扫描和吲哚菁绿清除率常数变化更大。第二组患者发生急性细菌感染的频率高于第一组患者。住院期间(24±2天),第二组有6例患者发生菌血症,第一组无患者发生菌血症(p<0.05)。随访期间(28±3个月),第二组有5例患者发生菌血症,第一组无患者发生菌血症(p<0.05)。在3个月(100%对80%)、6个月(94%对68%)、24个月(74%对42%)和48个月(68%对34%)时,第一组患者的累积生存率高于第二组患者(p<0.05)。我们认为,网状内皮系统吞噬活性降低的失代偿期肝硬化患者发生菌血症的风险很大,并且网状内皮系统吞噬活性在肝硬化中具有预后价值。